Semaglutide plus lifestyle changes moved 40.4% of children below the obesity threshold at 68 weeks in the phase 3 STEP Young trial.
|Articles|October 1, 2012
Childhood obesity a risk for developing gallstones
Children who are overweight or obese, especially girls, face an increased risk for developing gallstone disease compared with their normal-weight peers, according to research by Kaiser Permanente Southern California.
Advertisement
Advertisement
Related to this article
Semaglutide cut testosterone by half in early trial data — but one patient's rapid weight loss revealed a real risk. Our experts weigh the promise of GLP-1 therapy against how fast is too fast for teens.
Which labs actually change management? Our experts debate fasting insulin versus A1c, explain why total testosterone can mislead, and share the LH-to-FSH trick that helps settle ambiguous cases.
Most patients meet PMOS in a primary care office first. Our experts map the referral threshold and argue insulin resistance — not just androgens — should drive how aggressively PCPs treat.
Ovarian ultrasound doesn't apply to teens. Our experts walk through the 2-criteria threshold for adolescents, the "at risk" category, and why untreated menstrual irregularity carries real long-term consequences.
A global Lancet consensus just renamed PCOS to PMOS. Our experts explain why the shift moves care beyond the ovaries — and what it means for how clinicians talk to patients today.
Melissa Wallach, MD, FAAP, discusses what pediatricians should know about updated screening, supplementation, and treatment recommendations for iron deficiency.
A Bifidobacterium-based synbiotic was well tolerated and increased colonization of administered strains in infants and toddlers.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
How Breast Milk Shapes Gut Microbiome Signaling and Immunity
2
Teen sports supplements: What to recommend, use with caution, and avoid
3
Atopic dermatitis linked to higher ADHD risk in children, with sleep disturbance emerging as key factor
4
Bifidobacterium-based synbiotic shows safety and gut colonization in infants and toddlers
5